In this study we performed RNA-seq at different depths of poly A+ cDNA libraries from three different sample types-human bronchial epithelial (HBE) cells in culture, bronchial brushes, and whole lung
We developed preclinical PDX models, recapitulating the molecular heterogeneity of MIBCs and UTUC, which will represent an essential tool in therapy development. Pharmacological characterization of th
Leiomyosarcoma (LMS) is a malignant neoplasm with smooth muscle differentiation. Little is known about its molecular heterogeneity and no targeted therapy currently exists for LMS. We demonstrate the